New migraine pill shows promise in 100-Patient study
NCT ID NCT05903040
First seen Jan 25, 2026 · Last updated May 01, 2026 · Updated 14 times
Summary
This study looked at how well and how safely lasmiditan works for treating migraines quickly. One hundred people with different types of migraines took the drug and reported their pain levels and any side effects. The main goal was to see if they were pain-free within 2 hours after taking it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
IRCCS National Neurological Institute "C. Mondino" Foundation
Pavia, 27100, Italy
-
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
Florence, 50134, Italy
Conditions
Explore the condition pages connected to this study.